Eton Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2018 | $-8.1M | $-8.4M | $236.0K | $1.9M |
| FY2019 | $-18.0M | $-19.1M | $1.1M | $1.9M |
| FY2020 | $-22.3M | $-22.4M | $50.0K | $2.6M |
| FY2021 | $-4.7M | $-4.7M | $9.0K | $3.4M |
| FY2022 | $4.8M | $4.8M | $38.0K | $4.2M |
| FY2023 | $6.8M | $6.8M | $0 | $3.1M |
| FY2024 | $969.0K | $943.0K | $26.0K | $3.2M |
| FY2025 | $10.5M | $10.2M | $333.0K | $5.5M |